2023
DOI: 10.1080/22221751.2023.2217951
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of mortality from extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia

Abstract: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) bacteremia can have poor clinical outcomes. Thus, determining the predictors of mortality from ESBL-PE bacteremia is very important. The present systematic review and meta-analysis aimed to evaluate studies to determine predictors associated with ESBL-PE bacteremia mortality. We searched PubMed and Cochrane Library databases for all relevant publications from January 2000 to August 2022. The outcome measure was mortality rate. In this syst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…Therefore, the spread of ESBL/AmpC-producing Gram-negative bacteria poses a growing concern worldwide and is of clinical and epidemiological importance [2]. The case fatality rate for ESBL-producing Enterobacterales infections ranges between 12% and 41% [3], and the in-hospital costs of a single ESBL infection reach up to US$30,093 [4]. Similarly, higher Antibiotics 2023, 12, 1528 2 of 13 mortality and increased hospital costs were observed for patients infected with AmpCproducing bacteria compared with susceptible isolates of the same organisms [5].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the spread of ESBL/AmpC-producing Gram-negative bacteria poses a growing concern worldwide and is of clinical and epidemiological importance [2]. The case fatality rate for ESBL-producing Enterobacterales infections ranges between 12% and 41% [3], and the in-hospital costs of a single ESBL infection reach up to US$30,093 [4]. Similarly, higher Antibiotics 2023, 12, 1528 2 of 13 mortality and increased hospital costs were observed for patients infected with AmpCproducing bacteria compared with susceptible isolates of the same organisms [5].…”
Section: Introductionmentioning
confidence: 99%